Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis

Internal Medicine

Volumn 45, Issue 1, 2006, Pages 11-13

  Miyashita, Yasushi ^a   Monden, Tsuyoshi ^a   Yamamoto, Kayo ^a   Matsumura, Mihoko ^a   Kawagoe, Nobuaki ^a   Iwata, Chigusa ^a   Banba, Nobuyuki ^a   Hattori, Yoshiyuki ^a   Kasai, Kikuo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Hypokalemia; Steroid; Thyrotoxic periodic paralysis; Ventricular fibrillation

Indexed keywords

METHYLPREDNISOLONE; POTASSIUM; THIAMAZOLE; THYROID HORMONE;

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EPIDURAL HEMATOMA; GRAVES DISEASE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPOKALEMIA; MALE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; POTASSIUM BLOOD LEVEL; SINUS RHYTHM; THYROID CRISIS;

ADULT; GLUCOCORTICOIDS; HUMANS; HYPOKALEMIA; HYPOKALEMIC PERIODIC PARALYSIS; MALE; METHYLPREDNISOLONE; SEVERITY OF ILLNESS INDEX; VENTRICULAR FIBRILLATION;

EID: 32144450439     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1495     Document Type: Article

References (12)

1. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore) 71: 109-120, 1992.
2. Okinaka S, Shizume K, Iino S, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab 17: 1454-1459, 1957.
3. Mellgren G, Bleskestad IH, Aanderud S, Bindoff L. Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature. Thyroid 12: 77-80, 2002.
4. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. Hyperinsulinemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol 41: 213-216, 1994.
5. Monoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 159: 601-606, 1999.
6. Fraser CL, Swanson RA. Female sex hormones inhibit volume regulation in rat brain astrocyte culture. Am J Physiol 267: C909-914, 1994.
7. Dias Da Silva MR, Cerutti JM, Aranaldi LAT, Maciel RM. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 87: 4881-4894, 2002.
8. Kung AWC, Lau KS, Fong GCY, Chan V. Association of novel single nucleotide polymorphisms in the calcium channel al subunit gene (Cav 1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 89: 1340-1345, 2004.
9. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med 142: 1362-1364, 1982.
10. Kawaguchi M, Iwata S, Kamiya Y, et al. Thyroid storm associated with probable subclinical hypoadrenocorticism in an elderly woman. Intern Med 31: 1236-1238, 1992.
11. Metejka G, Verges B, Vaillant G, et al. Intravenous methylprednisolone pulse therapy in treatment of Graves' ophthalmopathy. Horm Metab Res 30: 93-98, 1998.
12. Lin SH, Lin YF, Haperin ML. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Disease 37: 620-630, 2001.